Vasopressin receptors and pharmacological chaperones: From functional rescue to promising therapeutic strategies. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Pharmacological Research Année : 2014

Vasopressin receptors and pharmacological chaperones: From functional rescue to promising therapeutic strategies.

Résumé

Conformational diseases result from protein misfolding and/or aggregation and constitute a major public health problem. Congenital Nephrogenic Diabetes Insipidus is a typical conformational disease. In most of the cases, it is associated to inactivating mutations of the renal arginine-vasopressin V2 receptor gene leading to misfolding and intracellular retention of the receptor, causing the inability of patients to concentrate their urine in response to the antidiuretic hormone. Cell-permeable pharmacological chaperones have been successfully challenged to restore plasma membrane localization of the receptor mutants and to rescue their function. Interestingly, different classes of specific ligands such as antagonists (vaptans), agonists as well as biased agonists of the V2 receptor have proven their usefulness as efficient pharmacochaperones. These compounds represent a potential therapeutic treatment of this X-linked genetic pathology.
Fichier principal
Vignette du fichier
ReviewPC.pdf (183.14 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-00909101 , version 1 (25-11-2013)

Identifiants

Citer

Bernard Mouillac, Christiane Mendre. Vasopressin receptors and pharmacological chaperones: From functional rescue to promising therapeutic strategies.. Pharmacological Research, 2014, 83, pp.74-8. ⟨10.1016/j.phrs.2013.10.007⟩. ⟨inserm-00909101⟩
259 Consultations
603 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More